Crude up in Asia on upbeat US manufacturing data
Top Stories
- Trouble mounts for Sreesanth as Mumbai cops gather more evidence
- SIT to seek Supreme Court guidance on Maya Kodnani death penalty issue
- Tamil Nadu police bans Yasin Malik-linked pro-Eelam public meeting
- Kings XI Punjab end IPL 2013 campaign with a win
- Narendra Modi: India losing sheen as agricultural nation

Crude was higher in Asia today after data showed the US manufacturing sector bounced back in September following three months of contraction, analysts said.
New York's main contract, light sweet crude for delivery in November, added three cents to USD 92.51 a barrel and Brent North Sea crude for November delivery gained 16 cents to USD 112.35.
"Oil advanced... as US manufacturing unexpectedly expanded," Phillip Futures said in a report.
Data released by the Institute for Supply Management late Monday showed US factory activity for September rising to 51.5, the first time since May that the index has risen above 50.
Any reading above 50 indicates an expansion in the sector, while one below that figure indicates a contraction.
The index had remained stubbornly below 50 for the past three months, contributing to the weak sentiment in energy markets as the US is the world's largest oil consumer and its manufacturing sector is a key driver of demand.
Editors’ Pick
- Destitute, orphan students outclass rest in Andhra Class 10 exams
- To re-energise ties, PM wants to visit US, waits for confirmation
- NIA court says no terror link, frees 'Hizbul militant' Liyaqat on bail
- CBI arrests its coal allotments investigator on bribery charge
- ‘Cricketer-bookie Amit may have used Jiju to reach Sree’
- BCCI chief N Srinivasan says police must prove spot-fixing allegations
- As it all sinks in, Sreesanth breaks down in tears, 'accepts mistake'


Kelkar panel on natural gas pricing likely to endorse Rangarajan formula
33% Indians feel offering cash to win biz is justified: Survey
MSCI world share index puts stocks worldwide at 5-yr high as data, central banks support
GlaxoSmithKline Pharma Q1 net profit up 37.52%




















